Skip to content

Main Navigation

Latham BioPharm Group logo

978.266.9151
  • About Us
    • Who We Are / Mission and Values
    • Business Model / Value Proposition
    • Leadership Team
    • Consultants
  • Services
    • Non-dilutive Funding
      • Government Relations
      • Proposal Development
      • Post-award Support
      • Contract Compliance
    • Product Development
      • CMC
      • Regulatory
      • Clinical
      • Nonclinical
      • Discovery
      • Quality
      • Project Management
      • Vendor Management
    • Strategic Consulting
      • Strategic Planning
      • Financial Modeling
      • Market Research
      • Supply Chain Network Development & Optimization
      • Market Access / Launch
      • Due Diligence
      • Technology Scouting
  • Expertise
    • Product Types
      • Vaccines
      • Therapeutics
      • Small Molecules
      • Cell & Gene Therapies
      • Medical Devices
      • Diagnostics
      • Health IT
      • MCMs
      • Animal Health
    • Sectors
      • LBG Biologics
      • LBG Animal Health
      • LBG Pharma
      • LBG MD&D (Medical Devices, Diagnostics, and Health IT)
  • Media / Collateral
    • Press Releases
    • News
    • Events
    • Collateral
    • Case Studies
  • Careers
    • Working at LBG
    • Current Opportunities
  • Contact Us
    • Locations
    • Request a Meeting

Press Releases

  • Press Releases
  • News
  • Events
  • Collateral
  • Case Studies

Press Releases

Press Release

Latham BioPharm Group Enhances its Discovery, Nonclinical, and Animal Health (DNA) Service Sector

View Press Release
Press Release

Latham BioPharm Group enhances its Non-dilutive Funding capabilities – adds contract compliance offering.

View Press Release
Press Release

Latham BioPharm Group Continues its Expansion

View Press Release
Press Release

Latham BioPharm Group adds Dr. Thijs Beuming and expands consulting offering to include In Silico Drug Discovery services.

View Press Release
Press Release

Latham BioPharm Group, a leading life science consulting firm, expands and opens new Baltimore, MD office.

View Press Release

Interested in our services?

Contact us today to set up an appointment.

Get Started

Footer Navigation

  • About Us
  • Services
    • Non-dilutive Funding
    • Product Development
    • Strategic Consulting
  • Expertise
    • Product Types
    • Sectors
  • Media / Collateral
    • Press Releases
    • News
    • Events
    • Collateral
    • Case Studies
  • Careers
  • Contact Us

Contact Information

Follow Us
  • LinkedIn
Latham BioPharm Group
Phone: 978.266.9151
Email: Email Us

© Latham BioPharm Group. All rights reserved.